BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy where the identity of the reviewers was known to the editors, authors and readers. The merged journal also adopted a fully open peer review policy. Two years on we discuss the views and experiences of our Editorial Board Members towards open peer review on this biomedical journal.
CITATION STYLE
Moylan, E. C., Harold, S., O’Neill, C., & Kowalczuk, M. K. (2014). Open, single-blind, double-blind: Which peer review process do you prefer? BMC Pharmacology and Toxicology. BioMed Central Ltd. https://doi.org/10.1186/2050-6511-15-55
Mendeley helps you to discover research relevant for your work.